✦ LIBER ✦

Antibiotic treatment of active Crohn's disease: Results of a multicentre, double blind, randomised, placebo-controlled trial with rifaximin (Grace 01)

✍ Scribed by M.L. Seribano; H. Lochs; M. Campieri; G.C. Sturniolo; F. Castiglione; M. Cottone; C. Prantera

Book ID: 119631810
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 400 KB
Volume: 38
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(06)80005-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibiotic treatment of Crohn's disease:

Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin

✍ C. PRANTERA; H. LOCHS; M. CAMPIERI; M. L. SCRIBANO; G. C. STURNIOLO; F. CASTIGLI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

Treatment of postoperative ileus with ch

Treatment of postoperative ileus with choline citrate—results of a prospective, randomised, placebo-controlled, double-blind multicentre trial

✍ Torsten Herzog; Hans P. Lemmens; Georg Arlt; Roland Raakow; Arved Weimann; Andre 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 205 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease

✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des

Treatment of Duchenne muscular dystrophy

Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial

✍ Janbernd Kirschner; Joachim Schessl; Ulrike Schara; Bernd Reitter; Georg M Stett 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 219 KB

T2020 No Clinical Benefit of Prebiotics

T2020 No Clinical Benefit of Prebiotics in the Treatment of Active Crohn's Disease: A Double-Blind, Randomised, Placebo-Controlled Trial

✍ Benjamin, Jane L.; Hedin, Charlotte R.; Koutsoumpas, Andreas; Ng, Siew C.; Hart, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Efficacy of rifaximin in the treatment o

Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial

✍ C. PAPI; A. CIACO; M. KOCH; L. CAPURSO 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB